The American Journal of Psychiatry has once again received recognition from New England Journal of M...

Long-term treatment with valbenazine for tardive dyskinesia (TD) appears to be safe and well-tolerat...

Teva Pharmaceuticals Ltd. on Wednesday announced that the Food and Drug Administration has approved ...

The Food and Drug Administration on Tuesday announced it approved Ingrezza (valbenazine) capsules to...

Once-daily treatment with valbenazine (NBI-98854), a highly selective vesicular monoamine transport ...

Psychoeducation appears to improve long-term medication adherence in patients with schizophrenia, le...

Elements of package inserts for second-generation antipsychotic medications aimed at both physicians...

Balazs Justin/Shutterstock A new Chinese study, reported in the Journal of Clinical Psychiatry, has ...